Rebecca Hedrick

Rebecca Hedrick

Auto-generated profile, based on publicly available information

Rebecca Hedrick

Department of Psychiatry and Behavioral Neurosciences; Cedars-Sinai Medical Center; 8730 Alden Dr. Suite E137, Los Angeles, California 90048

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in Academic Pediatrics
Verified
Journal Article
Open access
JCJaime La Charite
Jaime La Charite
JMJames Macinko
James Macinko
RHRebecca Hedrick
Rebecca Hedrick
MSMercedes Santoro
Mercedes Santoro
RDRebecca Dudovitz
Rebecca Dudovitz
Expanding access to extracurricular activities (EA) may help address the growing mental health needs of children and caregivers. Evidence supports that EA may benefit child mental health, but few studies explore whether this association is influenced by child and EA factors. Further, the impact of EA on caregivers remains unknown. We conducted a secondary analysis of the 2019 National Survey of Children's Health (NSCH), a nationally representative sample of children and their caregivers. We used responses from caregivers of children aged 6-17. Weighted logistic regressions tested associations between EA and 1) child anxiety and/or depression diagnosis, 2) caregiver mental health and 3) parental aggravation, controlling for child, family, and neighborhood-level covariates. Interaction terms tested whether associations were moderated by child age, sex, and presence of physical, developmental, or behavioral condition. Sub-analyses explored whether results varied by EA number and type. Weighted sample included 21,259 children. There were disparities in which children were engaged in EA. EA participation was associated with lower odds of a 1) child being diagnosed with anxiety and/or depression; 2) caregiver reporting "fair/poor" mental health, and 3) caregiver reporting "usually/always" experiencing parental aggravation. Child age, sex, EA number and type, but not health condition, influenced the relationship between EA and child anxiety and/or depression diagnosis. Access to EA is associated with child mental health and family functioning. Further studies should assess causality and specific mechanisms of action.

7 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WIWaguih William IsHak
Waguih William IsHak
SKSamuel Korouri
Samuel Korouri
TDTarneem Darwish
Tarneem Darwish
BVBrigitte Vanle
Brigitte Vanle
JDJonathan Dang
Jonathan Dang
IDItai Danovitch
Itai Danovitch
Objectives: Heart Failure is a chronic syndrome affecting over 5.7 million in the US and 26 million adults worldwide with nearly 50% experiencing depressive symptoms. The objective of the study is to compare the effects of two evidence-based treatment options for adult patients with depression and advanced heart failure, on depressive symptom severity, physical and mental health related quality of life (HRQoL), heart-failure specific quality of life, caregiver burden, morbidity, and mortality at 3, 6 and 12-months. Methods: Trial design. Pragmatic, randomized, comparative effectiveness trial. Interventions. The treatment interventions are: (1) Behavioral Activation (BA), a patient-centered psychotherapy which emphasizes engagement in enjoyable and valued personalized activities as selected by the patient; or (2) Antidepressant Medication Management administered using the collaborative care model (MEDS). Participants. Adults aged 18 and over with advanced heart failure (defined as New York Heart Association (NYHA) Class II, III, and IV) and depression (defined as a score of 10 or above on the PHQ-9 and confirmed by the MINI International Neuropsychiatric Interview for the DSM-5) selected from all patients at Cedars-Sinai Medical Center who are admitted with heart failure and all patients presenting to the outpatient programs of the Smidt Heart Institute at Cedars-Sinai Medical Center. We plan to randomize 416 patients to BA or MEDS, with an estimated 28% loss to follow-up/inability to collect follow-up data. Thus, we plan to include 150 in each group for a total of 300 participants from which data after randomization will be collected and analyzed. Conclusions: The current trial is the first to compare the impact of BA and MEDS on depressive symptoms, quality of life, caregiver burden, morbidity, and mortality in patients with depression and advanced heart failure. The trial will provide novel results that will be disseminated and implemented into a wide range of current practice settings. Registration: ClinicalTrials.Gov Identifier: NCT03688100.

1 October 2017 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
SDSeema Desai
Seema Desai
ASAlan Schlechter
Alan Schlechter
MKMari Kurahashi
Mari Kurahashi
RHRebecca Hedrick
Rebecca Hedrick
SZSarah Zoogman
Sarah Zoogman